Clinical Trials Logo

Filter by:
NCT ID: NCT00560378 Completed - Dermatitis, Atopic Clinical Trials

Long-term Safety of Protopic in Atopic Eczema

Start date: June 1998
Phase: Phase 3
Study type: Interventional

Patients who have participated in previous studies with Tacrolimus ointment for atopic eczema are entitled to enter this four-year follow study to investigate the safety of treatment with Tacrolimus ointment 0.1%

NCT ID: NCT00560326 Completed - Dermatitis, Atopic Clinical Trials

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Start date: June 2003
Phase: Phase 2
Study type: Interventional

The objective of this study is to assess the safety and efficacy of 0.03% tacrolimus ointment as long-term treatment in paediatric patients with atopic dermatitis.

NCT ID: NCT00559585 Completed - Clinical trials for Rheumatoid Arthritis (RA)

Methotrexate-Inadequate Response Study

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether a weekly subcutaneous dose of abatacept yields clinical efficacy comparable to that of monthly intravenous doses of abatacept in participants with rheumatoid arthritis and an inadequate response to current methotrexate therapy.

NCT ID: NCT00557466 Completed - COPD Clinical Trials

A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: October 2007
Phase: Phase 2
Study type: Interventional

This study will evaluate the dose response relationship among four doses of indacaterol as well as placebo delivered via the TWISTHALER® device.

NCT ID: NCT00553553 Recruiting - Pain Clinical Trials

Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery

RITM-IVM
Start date: September 2007
Phase: N/A
Study type: Interventional

The patient population requiring hepatic resection can demonstrate an unpredictable risk of exhibiting peri-operative coagulopathy resulting either from the pre-operative hepatic pathophysiology or volume of parenchymal resection. Choice of analgesia can be severely limited. Currently, the most commonly described use of combined remifentanil infusion and intrathecal morphine has been in fast-track cardiac surgery. To date, there are no published data describing its use in the context of major hepatobiliary where the investigators predict it may provide adequate analgesia with a lower rate of adverse effects over the first 24 hours after surgery.

NCT ID: NCT00553267 Completed - Hypertension Clinical Trials

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Start date: November 2007
Phase: Phase 3
Study type: Interventional

The primary objective of this trial is to demonstrate that the fixed dose combination of telmisartan 40mg + amlodipine 10mg (T40/A10) or the fixed dose combination of telmisartan 80mg + amlodipine 10mg (T80/A10) is superior in reducing blood pressure at eight weeks compared with amlodipine 10mg monotherapy (A10) in patients who fail to respond to six weeks treatment with A10.

NCT ID: NCT00552799 Completed - Clinical trials for Cellulitis/Erysipelas of the Leg

RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg

PATCH1
Start date: July 2006
Phase: Phase 4
Study type: Interventional

To assess whether a period of prophylactic penicillin after an episode of cellulitis of the leg reduces the risk of repeat episodes. Participants are randomised to receive 12 months of prophylaxis (penicillin VK 250mg b.d. or placebo). The PATCH I study will recruit only patients with recurrent disease.

NCT ID: NCT00551616 Completed - Contraception Clinical Trials

Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

Start date: April 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.

NCT ID: NCT00549302 Completed - Clinical trials for Hypertension, Pulmonary

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Start date: December 2005
Phase: Phase 3
Study type: Interventional

Study to determine the long term safety of tadalafil in patients with increased blood pressure in the blood vessel that carries blood from the right heart to the lungs and to see if it will keep the disease from getting worse.

NCT ID: NCT00549198 Completed - HIV Infection Clinical Trials

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

ASSERT
Start date: June 2007
Phase: Phase 4
Study type: Interventional

Recently, the fixed-dose combinations (FDC) KIVEXAâ„¢ (abacavir/lamivudine) and TRUVADA (tenofovir disoproxil fumarate/emtricitabine) have facilitated the usage of once-daily regimens. However data from head-to-head randomized trials comparing these two FDCs as part of an initial regimen are not available at present. The long-term toxicity profiles of these regimens are of particular importance, as treatment of HIV is currently life-long and therefore, minimizing long-term toxicity and maximizing adherence and duration of regimen maintenance are critical therapy objectives. The primary endpoint is estimated glomerular filtration rate (GFR), as measured by the modified diet in renal disease (MDRD) equation, a validated estimate of renal function.